Angiogenesis
Apoptosis
Autophagy & Proteolysis
Cancer & Cell Proliferation
Cell Surface Antigens
Cellular Stress
Cytokines & Growth Factors
Epigenetics
Epitope Tags
Fluorescent Proteins
GPCR
In Vitro Diagnostics
Inflammation & Immunology
Metabolism
Molecular Biology
Neuroscience
Signal Transduction
Solute Carrier
Virology
Other
Product Catalog |
CDK4 Monoclonal AntibodyCode No: K0065-3
Target:
Cdk4 Background:
Cdk4 (Cyclin-Dependent Kinase 4) is a 34 kDa kinase involved in the control of cell proliferation and progression between the G1 and S phases of the cell cycle. Cdk4 acts as a G1 checkpoint; it is constitutively expressed and the assembly of cyclin D/Cdk4 complexes is the rate-limiting step in progression through the G1 stage of the cell cycle. p16, a putative tumor suppressor, also plays a role in cell cycle regulation by binding to and inhibiting Cdk4 in competition with cyclin D. Upregulation of the cyclin D/Cdk4/6 complex is associated with the early stages of neuronal apoptosis, and the cyclin D/Cdk4 complex phosphorylates pRB (retinoblastoma gene product). Since p16 and pRB activity are inactivated or modified in a wide variety of human cancers, Cdk inhibitors such as Cdk4 may have therapeutic potential as anti-cancer drugs.
Size:
100 μg
Application:
WB
Application:
IHC
Clone Number:
DCS-156
Concentration:
1 mg/mL
Product Type:
Primary Antibody
Host Species:
Mouse
Species Reactivities:
Human
Species Reactivities:
Mouse
Isotype:
IgG1
Storage Temp. (°C):
-20
Shipping Temp. (°C):
4 Pictures:
 References:
1) Lukas, C., et al., Hybridoma 18, 225-234 (1999) Formulation:
100 g IgG in 100 L volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.
Reactivity:
This antibody reacts with human and mouse Cdk4.
Intended Use:
For Research use only. Not for use in diagnostic procedure. |
